Implementing and Evaluating a Patient-Centered PTSD Treatment Program for Military Personnel
PI | Alan L. Peterson, PhD, ABPP (Lt Col, US Air Force, Ret.) & Vanessa Jacoby, PhD |
Location(s) | Killeen, TX |
Aim | Conduct a partially randomized preference trial to evaluate the relationships between patient characteristics, preferences, treatment engagement, and outcomes for military members who engage in a shared-decision-making pre-intervention followed by evidence-based treatment. Also evaluate the impact of shared decision making on PTSD treatment completion and symptom reduction. |
Status | Recruitment of participants is expected to begin in Fall 2024 |
Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE) for mTBI: A Targeted, Randomized Controlled Trial
PI | Anthony Kontos, PhD |
Location(s) | Killeen, Texas, and Pittsburgh, Pennsylvania |
Aim | Evaluate a combination therapy for vestibular rehabilitation and psychological health following a mild traumatic brain injury. Determine whether it reduces vestibular symptoms and functional impairment more quickly and effectively than usual care. Look for predictors of treatment response that can guide future personalized care approaches. |
Status | Expected to begin recruitment in summer/fall of 2024 |
A Randomized Clinical Trial of Quetiapine Monotherapy vs. Treatment as Usual Polypharmacy for Postconcussive Syndrome in Veterans
PI | Muhammad Rais Baig, MD |
Location(s) | San Antonio, Texas, and Albuquerque, New Mexico |
Aim | Evaluate the effectiveness of quetiapine as a single medication therapy for postconcussive syndrome compared to treatment as usual with multiple medications following a mild traumatic brain injury (mTBI). Determine whether quetiapine effectively reduces postconcussive symptoms and functional disability and improves quality of life. Explore whether it enhances recovery by reducing medication side effects and increasing engagement in rehabilitation services. |
Status | San Antonio site is currently recruiting; New Mexico site expected to start recruitment in Fall 2024 |
Combining Stellate Ganglion Block with Prolonged Exposure for PTSD: A Randomized Clinical Trial
PI | Alan L. Peterson, PhD, ABPP (Lt Col, US Air Force, Ret.) |
Location(s) | San Antonio, TX, and Killeen, TX |
Aim | Evaluate the efficacy of a stellate ganglion block (SGB) injection combined with massed Prolonged Exposure therapy (massed PE) for the treatment of PTSD in active duty military personnel. |
Status | Study currently open for recruitment in San Antonio |
Randomized Controlled Trial of Intensive Multi-Couple Group Therapy for PTSD Versus Relationship Education in Military Couples
PI | Steffany Fredman, PhD |
Location(s) | Recruitment in South & Central Texas for retreats in San Antonio |
Aim | Test an abbreviated, intensive, multi-couple group version of Cognitive-Behavioral Conjoint Therapy for PTSD in comparison to an established couples’ relationship education program. Evaluate how effectively the interventions reduce service members’ and veterans’ PTSD and related symptoms and simultaneously reduce their partners’ psychological distress and improve couples’ relationship satisfaction. |
Status | Currently recruiting participants for upcoming retreats |
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
PI | Carmen McLean, PhD |
Location(s) | San Antonio, TX |
Aim | Conduct a pilot study to develop an optimal treatment schedule, followed by a randomized clinical trial to determine the efficacy of cognitive-behavioral treatment for insomnia and nightmares in reducing sleep problems when integrated with PTSD treatment and delivered in an accelerated treatment format. Also explore the impact of the added sleep treatment on PTSD symptoms. |
Status | Actively recruiting research participants |
An Effectiveness-Implementation Trial of Functional Restoration for Chronic Pain Management in Active Duty Military Personnel
PI | Alan L. Peterson, PhD, ABPP (Lt Col, US Air Force, Ret.) & Katherine Comtois, PhD |
Location(s) | Six U.S. Department of Defense Military Health System sites nationwide |
Aim | Evaluate the implementation and effectiveness of an evidence-based intervention for the nonpharmacological management of chronic pain in active duty military personnel. |
Status | Expect to begin enrolling participants in Spring 2025 |
Project MARCH: Multisite Advancement of Research on Chronic Posttraumatic Headache
PI | Donald McGeary, PhD |
Location(s) | Seven military and VA sites nationwide |
Aim | Compare the effectiveness of two forms of a manualized behavioral health intervention for posttraumatic headache (PTH) to usual care in a sample of U.S. military personnel and veterans with chronic PTH. |
Status | Currently enrolling research participants |
Pilot Study of Brain Stimulation Combined with Writing Therapy for PTSD
PI | Casey Straud, PsyD |
Location(s) | San Antonio, TX |
Aim | Evaluate the safety, feasibility, and psychological and physiological treatment benefits of transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique, when delivered in combination with Written Exposure Therapy for posttraumatic stress disorder. |
Status | Recruitment closed; researchers analyzing data and publishing study findings |
Assessment and Treatment of Chronic Anger and Aggression Following Military-Related Interpersonal and Institutional Betrayal: A Pilot Investigation
PI | Vanessa Jacoby, PhD, & Alan L. Peterson, PhD, ABPP (Lt Col, US Air Force, Ret.) |
Location(s) | Killeen, TX |
Aim | Test the acceptability and feasibility of Countering Chronic Anger and Aggression Related to Trauma and Transgressions (CCAARTT), an intervention designed to help service members and veterans heal after military-related betrayal, and prevent interpersonal violence in the military community. Test whether CCAARTT reduces problematic anger and aggression in military personnel with a history of military-related betrayal, improves interpersonal functioning, and reduces symptoms of PTSD, depression, anxiety, or suicidal ideation. |
Status | Recruitment of participants is expected to begin in Fall 2024. |